Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-030629
Date:2021-05-05
Issuer: ARCA BIOPHARMA, INC. (ABIO)
Original Submission Date:

Reporting Person:

CONWAY ROBERT E
10170 CHURCH RANCH WAY
SUITE 100 WESTMINSTER, CO 80021

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-05 P 10,000 a $3.23 40,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price represents the weighted average purchase price for multiple transactions reported on this line. the prices of the transactions ranged from$3.229 to $3.24. upon request of the sec staff, arca biopharma, inc. (the "company") or a security holder of the company, the reporting personwill provide full information regarding the number of shares purchased at each separate price.

Elevate your investments